Literature DB >> 32573975

Combined analysis of circRNA and mRNA profiles and interactions in patients with Diabetic Foot and Diabetes Mellitus.

Wanni Zhao1, Jianfeng Liang2, Zuoguan Chen3, Yongpeng Diao3, Gang Miao1.   

Abstract

In order to elucidate the pathogenesis and explore new biomarkers for diabetes and diabetic foot (DF), an analysis using RNA sequencing affords broader insights into gene expression regulatory networks in DF. To better explore the molecular basis of DF, we carried out an analysis of circular RNA (circRNA) and messenger RNA (mRNA) expression profiles of serum samples from DF patients and diabetes mellitus (DM) patients. The potential roles and interactions of differentially expressed circRNAs and mRNAs were classified by gene ontology enrichment and Kyoto Encyclopedia of Genes and Genomes pathway analyses. Compared with diabetes patients, 279 mRNAs were upregulated and 353 mRNAs were downregulated in the serum of DF patients, and 33 circRNAs were differently expressed. The differential genes at the nodes of the interaction network were screened, and TLR6 RUNX1 and ST2 were found to be related to the progression of diabetes and DF. The enrichment pathway analysis revealed that the lysosomal pathway played a critical role in the occurrence and development of DF. TLR6, RUNX1, and ST2 mRNA expressions and the lysosomal pathway may be involved in the pathogenesis of diabetes and DF. In addition, methane metabolism and Chagas disease pathways were observed in the occurrence and development of DF, which is a new discovery in this study. This study provides clues on the molecular mechanisms of DF at the circRNA and mRNA levels.
© 2020 Medicalhelplines.com Inc and John Wiley & Sons Ltd.

Entities:  

Keywords:  circRNA; diabetes mellitus; diabetic foot; mRNA

Year:  2020        PMID: 32573975      PMCID: PMC7949074          DOI: 10.1111/iwj.13420

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  30 in total

1.  Whole transcriptome analysis of diabetic nephropathy in the db/db mouse model of type 2 diabetes.

Authors:  Li Wen; Zheng Zhang; Rui Peng; Luyu Zhang; Handeng Liu; Huimin Peng; Yan Sun
Journal:  J Cell Biochem       Date:  2019-05-20       Impact factor: 4.429

Review 2.  Angiogenesis and scar formation in healing wounds.

Authors:  Luisa A DiPietro
Journal:  Curr Opin Rheumatol       Date:  2013-01       Impact factor: 5.006

3.  Endothelial progenitor cells from human fetal aorta cure diabetic foot in a rat model.

Authors:  Wan-Ni Zhao; Shi-Qing Xu; Jian-Feng Liang; Liang Peng; Hong-Lin Liu; Zai Wang; Qing Fang; Meng Wang; Wei-Qin Yin; Wen-Jian Zhang; Jin-Ning Lou
Journal:  Metabolism       Date:  2016-09-28       Impact factor: 8.694

4.  Mitochondrial ROS-induced lysosomal dysfunction impairs autophagic flux and contributes to M1 macrophage polarization in a diabetic condition.

Authors:  Yujia Yuan; Younan Chen; Tianqing Peng; Lan Li; Wuzheng Zhu; Fei Liu; Shuyun Liu; Xingxing An; Ruixi Luo; Jingqiu Cheng; Jingping Liu; Yanrong Lu
Journal:  Clin Sci (Lond)       Date:  2019-08-14       Impact factor: 6.124

5.  The emerging role of the epigenetic enzyme Sirtuin-1 and high mobility group Box 1 in patients with diabetic foot ulceration.

Authors:  Yasser Mostafa Hafez; Omnia Safwat El-Deeb; Marwa Mohamed Atef
Journal:  Diabetes Metab Syndr       Date:  2018-07-05

6.  Knockdown of GSK3β increases basal autophagy and AMPK signalling in nutrient-laden human aortic endothelial cells.

Authors:  Karen A Weikel; José M Cacicedo; Neil B Ruderman; Yasuo Ido
Journal:  Biosci Rep       Date:  2016-09-16       Impact factor: 3.840

Review 7.  Long non-coding RNAs: Mechanism of action and functional utility.

Authors:  Shakil Ahmad Bhat; Syed Mudasir Ahmad; Peerzada Tajamul Mumtaz; Abrar Ahad Malik; Mashooq Ahmad Dar; Uneeb Urwat; Riaz Ahmad Shah; Nazir Ahmad Ganai
Journal:  Noncoding RNA Res       Date:  2016-11-12

8.  RNA-seq data of invasive ductal carcinoma and adjacent normal tissues from a Korean patient with breast cancer.

Authors:  Ji Hyung Hong; Yoon Ho Ko; Keunsoo Kang
Journal:  Data Brief       Date:  2018-03-21

9.  Influence of SIRT1 polymorphisms for diabetic foot susceptibility and severity.

Authors:  Yi Peng; Guishan Zhang; Hongxia Tang; Luling Dong; Chunbin Gao; Xiuhong Yang; Ying Peng; Yanrong Xu
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.817

Review 10.  Interactions Among Non-Coding RNAs in Diabetic Nephropathy.

Authors:  Tamil Selvi Loganathan; Siti Aishah Sulaiman; Nor Azian Abdul Murad; Shamsul Azhar Shah; Abdul Halim Abdul Gafor; Rahman Jamal; Noraidatulakma Abdullah
Journal:  Front Pharmacol       Date:  2020-03-03       Impact factor: 5.810

View more
  5 in total

1.  Combined analysis of circRNA and mRNA profiles and interactions in patients with Diabetic Foot and Diabetes Mellitus.

Authors:  Wanni Zhao; Jianfeng Liang; Zuoguan Chen; Yongpeng Diao; Gang Miao
Journal:  Int Wound J       Date:  2020-06-23       Impact factor: 3.315

Review 2.  Cell Therapy for Critical Limb Ischemia: Advantages, Limitations, and New Perspectives for Treatment of Patients with Critical Diabetic Vasculopathy.

Authors:  Y Gu; A Rampin; V V Alvino; G Spinetti; P Madeddu
Journal:  Curr Diab Rep       Date:  2021-03-02       Impact factor: 4.810

3.  Profile and Functional Prediction of Plasma Exosome-Derived CircRNAs From Acute Ischemic Stroke Patients.

Authors:  Jie Yang; Junli Hao; Yapeng Lin; Yijia Guo; Ke Liao; Min Yang; Hang Cheng; Ming Yang; Kejie Chen
Journal:  Front Genet       Date:  2022-03-14       Impact factor: 4.599

4.  The protective mechanism of protein kinase R to inhibit neuronal ferroptosis in cerebral injury from subarachnoid hemorrhage.

Authors:  Jianwei Lei; Shuxin Song; Zhihua Chen; Sihong Shu; Qiang Liu; Wei Hu
Journal:  Brain Behav       Date:  2022-07-27       Impact factor: 3.405

Review 5.  Circular RNAs in diabetes mellitus and its complications.

Authors:  Wenqi Fan; Haipeng Pang; Zhiguo Xie; Gan Huang; Zhiguang Zhou
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-01       Impact factor: 6.055

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.